000 01553 a2200433 4500
005 20250515073947.0
264 0 _c20070809
008 200708s 0 0 eng d
022 _a0960-3271
024 7 _a10.1177/0960327106076812
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKopjar, Nevenka
245 0 0 _aCytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients.
_h[electronic resource]
260 _bHuman & experimental toxicology
_cMay 2007
300 _a391-9 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aBreast Neoplasms
_xblood
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aChemotherapy, Adjuvant
_xadverse effects
650 0 4 _aCytogenetic Analysis
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aLymph Node Excision
650 0 4 _aLymphocytes
_xdrug effects
650 0 4 _aMastectomy
650 0 4 _aMiddle Aged
650 0 4 _aSister Chromatid Exchange
_xdrug effects
650 0 4 _aTreatment Outcome
700 1 _aMilas, Ivan
700 1 _aGaraj-Vrhovac, Verica
700 1 _aGamulin, Marija
773 0 _tHuman & experimental toxicology
_gvol. 26
_gno. 5
_gp. 391-9
856 4 0 _uhttps://doi.org/10.1177/0960327106076812
_zAvailable from publisher's website
999 _c17158877
_d17158877